期刊文献+

BLCA-1、BLCA-4与膀胱癌关系的研究现状 被引量:6

原文传递
导出
摘要 膀胱癌是泌尿系统中最常见的恶性肿瘤之一。美国癌症协会预测2013年美国膀胱癌新发病例72570例,有15210例患者死于膀胱癌[1]。在我国膀胱肿瘤的发病率占泌尿系肿瘤的首位,同时发病率正在不断的攀升[2]。
出处 《中华临床医师杂志(电子版)》 CAS 2013年第18期185-187,共3页 Chinese Journal of Clinicians(Electronic Edition)
基金 深圳市战略性新兴产业发展专项资金项目(JCYJ20120614 155650545)
  • 相关文献

参考文献54

  • 1Siegel R,Naishadham D,Jemal A. Cancer statistics,2013[J].CA:A Cancer Journal for Clinicians,2013.11-30. 被引量:1
  • 2温登瑰,单保恩,张思维,郑荣寿,王寒松,张莉梅,毕学娟,陈万青.2003—2007年中国肿瘤登记地区膀胱癌的发病与死亡分析[J].肿瘤,2012,32(4):256-262. 被引量:83
  • 3Shelley MD,Mason MD,Kynaston H. Intravesical therapy for superficial bladder cancer:a systematic review of randomised trials and meta-analyses[J].Cancer Treatment Reviews,2010.195-205. 被引量:1
  • 4van Rhijn BW,van der Poel HG,van der Kwast TH. Cytology and Urinary Markers for the Diagnosis of Bladder Cancer[J].European Urology Supplements,2009.536-541. 被引量:1
  • 5Clark PE,Agarwal N,Biagioli MC. Bladder cancer[J].J Natl Compr Canc Netw,2013.446-475. 被引量:1
  • 6Tilki D,Burger M,Dalbagni G. Urine Markers for Detection and Surveillance of Non-Muscle-Invasive Bladder Cancer[J].European Urology,2011.484-492. 被引量:1
  • 7Getzenberg RH,Konety BR,Oeler TA. Bladder cancer-associated nuclear matrix proteins[J].Cancer Research,1996.1690-1694. 被引量:1
  • 8Fey EG,Bangs P,Sparks C. The nuclear matrix:defining structural and functional roles[J].Critical Reviews in Eukaryotic Gene Expression,1991.127-143. 被引量:1
  • 9Replogle-Schwab R,Pienta KJ,Getzenberg RH. The utilization of nuclear matrix proteins for cancer diagnosis[J].Critical Reviews in Eukaryotic Gene Expression,1996.103-113. 被引量:1
  • 10Huber S,Schwentner C,Taeger D. Nuclear matrix protein-22:a prospective evaluation in a population at risk for bladder cancer. Results from the UroScreen study[J].British Journal of Urology International,2012.699-708. 被引量:1

二级参考文献4

共引文献82

同被引文献88

  • 1张绍谨,刘红耀.尿膀胱癌抗原、核基质蛋白22和透明质酸诊断膀胱癌的临床价值[J].中华临床医师杂志(电子版),2011,5(24):7202-7205. 被引量:15
  • 2解放,孙晓刚,李岩,赵继明,牛志宏,吕家驹,丁森泰.力尔凡辅助吉西他滨联合顺铂治疗晚期膀胱癌的疗效观察[J].实用癌症杂志,2014,29(1):37-40. 被引量:4
  • 3Shelley MD, Mason MD, Kynaston H. Intravesical therapy for superf- icial bladder cancer: a systematic review of randomised trials and me- ta-analyses[J]. Cancer Treat Rev, 2010, 36(3): 195-205. 被引量:1
  • 4Clark PE, Agarwal N, Biagioli MC, et al. Bladder cancer [J]. Natl Co- mpr Canc Netw, 2013, 11 : 446-475. 被引量:1
  • 5Getzenberg RH, Konety BR, Oeler TA, et al. Bladder cancer-associate- d nuclear matrix proteins[J]. Cancer Res, 1996, 56(6): 1690-1694. 被引量:1
  • 6Fey EG, Bangs P, Sparks C, et al. The nuclear matrix: defining structu- ral and functional roles [J]. Crit Rev Eukaryot Gene Expr, 1991, 1(4): 127-143. 被引量:1
  • 7Fey EC, Bangs P, Sparks C, et al. The nuclear matrix:defining structu- ral and functional[J]. Crit Rev Eukaryiric Gene Expt, 1991, 1(38): 127 -144. 被引量:1
  • 8Oikawa T. ETS transcription factors: possible targets for cancer therapy[J]. Cancer Sci, 2004, 95(17): 626-633. 被引量:1
  • 9Myers-Irvin JM, Van Le TS, Getzenberg RH. Mechanistic analysis of the role of BLCA-4 in bladder cancer pathobiology [J]. Cancer Res, 2005, 65(1): 7145-7150. 被引量:1
  • 10Tilki D, Burger M, Dalbagni G, et al. Urine Markers for Detection and Surveillance of Non-Muscle-Invasive Bladder Cancer [J]. European Urology, 2011, 60(3): 484-492. 被引量:1

引证文献6

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部